Warning Model of Myocardial Remodeling After Acute Myocardial Infarction Using Multimodal Feature Structure Technology
Early Warning Model of Myocardial Remodeling After Acute Myocardial Infarction Based on Multimodal Feature Structure Technology
1 other identifier
observational
4,000
1 country
1
Brief Summary
Acute myocardial infarction (AMI) is one of the most important diseases threatening human life. The existing MI prognosis prediction scales mostly predict the incidence of death, recurrent MI and heart failure through 6-8 clinical text indicators, and the data are collected relatively simply. Myocardial remodeling, as an adverse pathological change that can start and continue to progress in the early stage after myocardial infarction, is the main pathological mechanism of heart failure and death. However, there is no quantitative early-warning model of myocardial remodeling, and the clinical guidance of early intervention is lacking. Our previous study found that cardiac magnetic resonance imaging can accurately quantify the necrotic area and recoverable myocardium in the edematous myocardium after myocardial infarction. In this study, machine learning algorithm, variable convolution network (DCN) and capsule network (capsnet) are used to build a new neural network architecture. Structural feature extraction of multi-modal clinical image data such as MRI and ultrasound is realized. Combined with the established database of 3000 patients with myocardial infarction, the multimodal feature matrix will be constructed, and a variety of classifiers such as support vector machine (SVM) and random forest (RF) will be used for quantitative prediction of myocardial remodeling, and the effects of different classifiers were evaluated. It is expected that this project will establish a quantitative early warning model of myocardial remodeling after acute myocardial infarction in line with the characteristics of Chinese people. The same type of data outside the database will be used for verification to establish an efficient and stable early warning model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2022
CompletedFirst Submitted
Initial submission to the registry
September 17, 2023
CompletedFirst Posted
Study publicly available on registry
October 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedApril 30, 2024
October 1, 2023
1.6 years
September 17, 2023
April 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Novel convolutional neural network algorithm and cardiac magnetic resonance imaging to evaluate the occurrence of myocardial remodeling.remodeling after myocardial infarction.
(Quantitative characterization of myocardial remodeling, cardiac magnetic resonance imaging quantifying necrotic areas and recoverable myocardium within the edematous myocardium after myocardial infarction).
1year
Secondary Outcomes (1)
The multi-dimensional indexes of existing database were compared with the location and course of myocardial remodeling by artificial intelligence method Degree of correlation analysis.
1year
Eligibility Criteria
Criteria for the diagnosis of acute myocardial infarction: increased or decreased cardiac biomarkers (preferably cTn), at least once exceeding the 99th percentile of the upper reference value, cut-off variability ≤10%, and at least one evidence of myocardial ischemia (including symptoms, electrocardiographic ischemic changes, pathological Q-waves, or imaging evidence).
You may qualify if:
- Patients with acute myocardial infarction, aged 18-80 years; 2.The time from onset to treatment is less than 72h 3.Myocardial enzyme Tni/Tnt(+).
You may not qualify if:
- Patients with malignant tumors; 2.Patients who could not receive conventional treatment 3.Patients who did not receive coronary angiography, lacking anatomical and imaging data; 4.Patients who have undergone cardiac surgery (except coronary artery bypass surgery)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xuanwu Hospital, Beijinglead
- Beijing Institute of Technologycollaborator
Study Sites (1)
Xuanwu Hospital, Capital Medical University
Beijing, Xicheng, 100000, China
Related Publications (25)
Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJ, Naghavi M. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation. 2014 Apr 8;129(14):1483-92. doi: 10.1161/CIRCULATIONAHA.113.004042. Epub 2014 Feb 26.
PMID: 24573352BACKGROUNDAbuomara HZA, Hassan OM, Rashid T, Baraka M. Myocardial performance index as an echocardiographic predictor of early in-hospital heart failure during first acute anterior ST-elevation myocardial infarction. Egypt Heart J. 2018 Jun;70(2):71-75. doi: 10.1016/j.ehj.2017.12.001. Epub 2017 Dec 24.
PMID: 30166885BACKGROUNDHausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013 Jan;123(1):92-100. doi: 10.1172/JCI62874. Epub 2013 Jan 2.
PMID: 23281415BACKGROUNDHendriks T, Schurer RAJ, Al Ali L, van den Heuvel AFM, van der Harst P. Left ventricular restoration devices post myocardial infarction. Heart Fail Rev. 2018 Nov;23(6):871-883. doi: 10.1007/s10741-018-9711-2.
PMID: 29770903BACKGROUNDIborra-Egea O, Galvez-Monton C, Roura S, Perea-Gil I, Prat-Vidal C, Soler-Botija C, Bayes-Genis A. Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach. NPJ Syst Biol Appl. 2017 Apr 18;3:12. doi: 10.1038/s41540-017-0013-4. eCollection 2017.
PMID: 28649439BACKGROUNDMcMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.
PMID: 25176015BACKGROUNDSeferovic PM, Fragasso G, Petrie M, Mullens W, Ferrari R, Thum T, Bauersachs J, Anker SD, Ray R, Cavusoglu Y, Polovina M, Metra M, Ambrosio G, Prasad K, Seferovic J, Jhund PS, Dattilo G, Celutkiene J, Piepoli M, Moura B, Chioncel O, Ben Gal T, Heymans S, Jaarsma T, Hill L, Lopatin Y, Lyon AR, Ponikowski P, Lainscak M, Jankowska E, Mueller C, Cosentino F, Lund LH, Filippatos GS, Ruschitzka F, Coats AJS, Rosano GMC. Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure. Eur J Heart Fail. 2020 Nov;22(11):1984-1986. doi: 10.1002/ejhf.2026. Epub 2020 Oct 27.
PMID: 33068051BACKGROUNDPasternak B, Ueda P, Eliasson B, Svensson AM, Franzen S, Gudbjornsdottir S, Hveem K, Jonasson C, Wintzell V, Melbye M, Svanstrom H. Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study. BMJ. 2019 Aug 29;366:l4772. doi: 10.1136/bmj.l4772.
PMID: 31467044BACKGROUNDWest R, Jones D. Cardiac rehabilitation and mortality reduction after myocardial infarction: the emperor's new clothes? Evidence against cardiac rehabilitation. Heart. 2013 Jul;99(13):911-3. doi: 10.1136/heartjnl-2013-303705. Epub 2013 May 4.
PMID: 23644409BACKGROUNDAnderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, Taylor RS. Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2016 Jan 5;67(1):1-12. doi: 10.1016/j.jacc.2015.10.044.
PMID: 26764059BACKGROUNDMilani RV, Lavie CJ. Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med. 2007 Sep;120(9):799-806. doi: 10.1016/j.amjmed.2007.03.026.
PMID: 17765050BACKGROUNDKaruzas A, Rumbinaite E, Verikas D, Ptasinskas T, Muckiene G, Kazakauskaite E, Zabiela V, Jurkevicius R, Vaskelyte JJ, Zaliunas R, Zaliaduonyte-Peksiene D. Accuracy of three-dimensional systolic dyssynchrony and sphericity indexes for identifying early left ventricular remodeling after acute myocardial infarction. Anatol J Cardiol. 2019 Jun;22(1):13-20. doi: 10.14744/AnatolJCardiol.2019.02844.
PMID: 31264652BACKGROUNDKagiyama N, Shrestha S, Cho JS, Khalil M, Singh Y, Challa A, Casaclang-Verzosa G, Sengupta PP. A low-cost texture-based pipeline for predicting myocardial tissue remodeling and fibrosis using cardiac ultrasound. EBioMedicine. 2020 Apr;54:102726. doi: 10.1016/j.ebiom.2020.102726. Epub 2020 Apr 6.
PMID: 32268274BACKGROUNDChirinos JA, Sardana M, Ansari B, Satija V, Kuriakose D, Edelstein I, Oldland G, Miller R, Gaddam S, Lee J, Suri A, Akers SR. Left Atrial Phasic Function by Cardiac Magnetic Resonance Feature Tracking Is a Strong Predictor of Incident Cardiovascular Events. Circ Cardiovasc Imaging. 2018 Dec;11(12):e007512. doi: 10.1161/CIRCIMAGING.117.007512.
PMID: 30562112BACKGROUNDRanka S, Reddy M, Noheria A. Artificial intelligence in cardiovascular medicine. Curr Opin Cardiol. 2021 Jan;36(1):26-35. doi: 10.1097/HCO.0000000000000812.
PMID: 33060388BACKGROUNDAhmad T, Lund LH, Rao P, Ghosh R, Warier P, Vaccaro B, Dahlstrom U, O'Connor CM, Felker GM, Desai NR. Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients. J Am Heart Assoc. 2018 Apr 12;7(8):e008081. doi: 10.1161/JAHA.117.008081.
PMID: 29650709BACKGROUNDMotwani M, Dey D, Berman DS, Germano G, Achenbach S, Al-Mallah MH, Andreini D, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Chinnaiyan K, Chow BJ, Cury RC, Delago A, Gomez M, Gransar H, Hadamitzky M, Hausleiter J, Hindoyan N, Feuchtner G, Kaufmann PA, Kim YJ, Leipsic J, Lin FY, Maffei E, Marques H, Pontone G, Raff G, Rubinshtein R, Shaw LJ, Stehli J, Villines TC, Dunning A, Min JK, Slomka PJ. Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis. Eur Heart J. 2017 Feb 14;38(7):500-507. doi: 10.1093/eurheartj/ehw188.
PMID: 27252451BACKGROUNDTokodi M, Schwertner WR, Kovacs A, Toser Z, Staub L, Sarkany A, Lakatos BK, Behon A, Boros AM, Perge P, Kutyifa V, Szeplaki G, Geller L, Merkely B, Kosztin A. Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score. Eur Heart J. 2020 May 7;41(18):1747-1756. doi: 10.1093/eurheartj/ehz902.
PMID: 31923316BACKGROUNDSanchez-Cabo F, Rossello X, Fuster V, Benito F, Manzano JP, Silla JC, Fernandez-Alvira JM, Oliva B, Fernandez-Friera L, Lopez-Melgar B, Mendiguren JM, Sanz J, Ordovas JM, Andres V, Fernandez-Ortiz A, Bueno H, Ibanez B, Garcia-Ruiz JM, Lara-Pezzi E. Machine Learning Improves Cardiovascular Risk Definition for Young, Asymptomatic Individuals. J Am Coll Cardiol. 2020 Oct 6;76(14):1674-1685. doi: 10.1016/j.jacc.2020.08.017.
PMID: 33004133BACKGROUNDCommandeur F, Slomka PJ, Goeller M, Chen X, Cadet S, Razipour A, McElhinney P, Gransar H, Cantu S, Miller RJH, Rozanski A, Achenbach S, Tamarappoo BK, Berman DS, Dey D. Machine learning to predict the long-term risk of myocardial infarction and cardiac death based on clinical risk, coronary calcium, and epicardial adipose tissue: a prospective study. Cardiovasc Res. 2020 Dec 1;116(14):2216-2225. doi: 10.1093/cvr/cvz321.
PMID: 31853543BACKGROUNDThan MP, Pickering JW, Sandoval Y, Shah ASV, Tsanas A, Apple FS, Blankenberg S, Cullen L, Mueller C, Neumann JT, Twerenbold R, Westermann D, Beshiri A, Mills NL; MI3 Collaborative. Machine Learning to Predict the Likelihood of Acute Myocardial Infarction. Circulation. 2019 Sep 10;140(11):899-909. doi: 10.1161/CIRCULATIONAHA.119.041980. Epub 2019 Aug 16.
PMID: 31416346BACKGROUNDTan JH, Hagiwara Y, Pang W, Lim I, Oh SL, Adam M, Tan RS, Chen M, Acharya UR. Application of stacked convolutional and long short-term memory network for accurate identification of CAD ECG signals. Comput Biol Med. 2018 Mar 1;94:19-26. doi: 10.1016/j.compbiomed.2017.12.023. Epub 2018 Jan 2.
PMID: 29358103BACKGROUNDD'Ascenzo F, De Filippo O, Gallone G, Mittone G, Deriu MA, Iannaccone M, Ariza-Sole A, Liebetrau C, Manzano-Fernandez S, Quadri G, Kinnaird T, Campo G, Simao Henriques JP, Hughes JM, Dominguez-Rodriguez A, Aldinucci M, Morbiducci U, Patti G, Raposeiras-Roubin S, Abu-Assi E, De Ferrari GM; PRAISE study group. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets. Lancet. 2021 Jan 16;397(10270):199-207. doi: 10.1016/S0140-6736(20)32519-8.
PMID: 33453782BACKGROUNDFernandez-Ruiz I. Machine learning predicts risk in ACS. Nat Rev Cardiol. 2021 Apr;18(4):230. doi: 10.1038/s41569-021-00521-8. No abstract available.
PMID: 33531699BACKGROUNDWang S, Zhao Y, Zhao Y, Wang Y, Fan Z, Liu Z. Construction and Clinical Relevance of a Predictive Model of Coronary Microcirculatory Dysfunction in Patients With Acute Myocardial Infarction Following Percutaneous Coronary Intervention. Rev Cardiovasc Med. 2025 Jun 30;26(6):38533. doi: 10.31083/RCM38533. eCollection 2025 Jun.
PMID: 40630444DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhi Liu
Xuanwu Hospital, Beijing
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 17, 2023
First Posted
October 2, 2023
Study Start
October 10, 2022
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
April 30, 2024
Record last verified: 2023-10